These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6252836)

  • 1. In vitro susceptibility of varicella-zoster virus to acyclovir.
    Biron KK; Elion GB
    Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of herpes virus isolates from acyclovir clinical trials.
    Collins P; Appleyard G; Oliver NM
    Am J Med; 1982 Jul; 73(1A):380-2. PubMed ID: 6285727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acyclovir combined with other antiherpetic agents on varicella zoster virus in vitro.
    Biron KK; Elion GB
    Am J Med; 1982 Jul; 73(1A):54-7. PubMed ID: 6285733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
    Biron KK; Fyfe JA; Noblin JE; Elion GB
    Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.
    Machida H
    Antimicrob Agents Chemother; 1986 Mar; 29(3):524-6. PubMed ID: 3013088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of varicella-zoster virus to thymidine analogues.
    Machida H
    Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
    Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
    Daikoku T; Shiraki K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).
    Collins P; Oliver NM
    Antiviral Res; 1985 Jun; 5(3):145-56. PubMed ID: 2992369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 13. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug.
    Lake-Bakaar DM; Abele G; Lindborg B; Soike KF; Datema R
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1807-12. PubMed ID: 2854453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2.
    Smith KO; Galloway KS; Kennell WL; Ogilvie KK; Radatus BK
    Antimicrob Agents Chemother; 1982 Jul; 22(1):55-61. PubMed ID: 6289741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds.
    Preblud SR; Arbeter AM; Proctor EA; Starr SE; Plotkin SA
    Antimicrob Agents Chemother; 1984 Apr; 25(4):417-21. PubMed ID: 6329079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2.
    Stanwick TL; Schinazi RF; Campbell DE; Nahmias AJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):672-4. PubMed ID: 6166248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
    Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
    Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and antiviral effect of acyclovir in cells infected with a varicella-like simian virus.
    Fyfe JA; Biron KK; McKee SA; Kelly CM; Elion GB; Soike KF
    Am J Med; 1982 Jul; 73(1A):58-61. PubMed ID: 6285734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.